The future lies in —technologies that turn the "volume up to 11" inside the cancer, but keep it silent in the heart, lung, and gut. The Takeaway For the past decade, we have been teaching the immune system to stop ignoring cancer. Global TIS Activation is the next step: teaching it to fight cancer with the same ferocity it fights the flu.
As we watch the data from ASCO and SITC over the next 18 months, look for the drugs that aren't just increasing T cell counts—but those that are changing the signature of the entire battlefield. global tis activation
For years, the battle cry in cancer immunotherapy has been “Release the brakes.” Checkpoint inhibitors (like anti-PD-1 and anti-CTLA-4) have changed the standard of care by blocking the signals that tell T cells to shut down. The future lies in —technologies that turn the
Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a physician regarding oncology treatments. As we watch the data from ASCO and